Dumoulin, Bernhard
Levinsohn, Jonathan https://orcid.org/0000-0003-4454-714X
Klötzer, Konstantin A. https://orcid.org/0009-0005-5022-2706
Li, Chenyu
Mao, Liran https://orcid.org/0009-0002-1542-4132
Ha, Eunji https://orcid.org/0000-0001-8618-8347
Mohandes, Samer
Nguyen, Thao
Paruzzo, Luca https://orcid.org/0000-0002-6505-0194
Hirohama, Daigoro https://orcid.org/0000-0002-1885-1263
Fang, Victoria
Bhoj, Vijay G.
Parhiz, Hamideh
Andrade-Silva, Magaiver
Abedini, Amin
Bergeson, Andi https://orcid.org/0009-0008-8128-6974
Traum, Daniel https://orcid.org/0000-0002-0195-5525
May, Michael J. https://orcid.org/0000-0002-2485-3716
Kaestner, Klaus H. https://orcid.org/0000-0002-1228-021X
Ruella, Marco https://orcid.org/0000-0003-4301-5811
McAllister, Fiona Elizabeth https://orcid.org/0000-0002-7862-6711
Hakimi, A. Ari https://orcid.org/0000-0002-0930-8824
Li, Mingyao https://orcid.org/0000-0001-8180-0621
Palmer, Matthew
Wherry, E. John https://orcid.org/0000-0003-0477-1956
Hunter, Christopher A. https://orcid.org/0000-0003-3092-1428
Cancro, Michael Paul
,
Townsend, Raymond
Coppock, Gaia
Singh, Manisha
Ross, Michael
Tumlin, James
Campbell, Kirk
Mottl, Amy
Argyropoulos, Christos
Isakova, Tamara
Almaani, Salem
Avasare, Rupali
Lafayette, Richard
Scialla, Julia
Luciano, Randy
Bansal, Shweta
Brosius, Frank
Mehta, Ankit
Lenz, Oliver
Kopyt, Nelson
Canetta, Piettro
Kretzler, Matthias
Schelling, Jeffrey
Hofherr, Alexis
Pullen, Steven S.
Thorley, Andrew
Shang, Ching
Hu, Erding
Karihaloo, Anil
Devalaraja-Narashimha, Kishor
Susztak, Katalin https://orcid.org/0000-0002-1005-3726
Article History
Received: 20 September 2024
Accepted: 4 March 2026
First Online: 29 April 2026
Competing interests
: The Susztak laboratory is supported by Boehringer Ingelheim, Regeneron, Bayer, GSK, Gilead, Novartis, KKC, Gilead, Genentech, ONO and Novo Nordisk for work that is unrelated to the current manuscript. E.J.W. is a member of the Parker Institute for Cancer Immunotherapy. E.J.W. is an advisor for Arpelos Bio, Arsenal Biosciences, Coherus, Danger Bio, IpiNovyx, New Limit, Marengo, Pluto Immunotherapeutics, Related Sciences, Santa Ana Bio and Synthekine. E.J.W. is a founder of Arpelos Bio, Arsenal Biosciences and Danger Bio, and holds stock in Coherus. The other authors declare no competing interests.